CrossRef Cited-by Linking Search Results

This Article:

has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking:

  • État des lieux et mise à jour des traitements systémiques adjuvants
    Thomas Bachelot, Kamel Bouzid, Thierry Delozier, Alain Lortholary, and Thierry Petit
    Oncologie (2011) 13 :698
  • Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers
    Namita Pendharkar, Akshada Gajbhiye, Khushman Taunk, Sourav RoyChoudhury, Snigdha Dhali, Shubhendu Seal, Anupama Mane, Subodhini Abhang, Manas K. Santra, Koel Chaudhury, and Srikanth Rapole
    Journal of Proteomics (2016) 132 :112
  • Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma
    Monica Neagu, Carolina Constantin, and Cristiana Tanase
    Expert Review of Molecular Diagnostics (2010) 10 :897
  • Radionuclide Response Assessment of Breast Cancer
    Lale Kostakoglu
    Seminars in Nuclear Medicine (2013) 43 :299
  • Phenotyping, Etiological Factors, and Biomarkers
    David Q. Beversdorf
    Journal of Developmental & Behavioral Pediatrics (2016) 37 :659
  • Progesterone receptor targeting with radiolabelled steroids: An approach in predicting breast cancer response to therapy
    Susana Cunha, Lurdes Gano, Goreti Ribeiro Morais, Thies Thiemann, and Maria Cristina Oliveira
    The Journal of Steroid Biochemistry and Molecular Biology (2013) 137 :223
  • Breast cancer resistance protein (BCRP)-containing circulating microvesicles contribute to chemoresistance in breast cancer
    Oncology Letters (2015) 10 :3742
  • Factores relacionados con la supervivencia libre de enfermedad en el cáncer de mama
    Cristina Dávila-Arias, Olga Ocón, Mariana F. Fernández, Juan Pedro Arrebola, María José Sánchez, José Aneiros, Pablo Torné, and Nicolás Olea
    Medicina Clínica (2014) 143 :293
  • Stratified medicine: a call for action
    Ian Jacob, Ahmad Hussein Awada, Katherine Payne, and Lieven Annemans
    Expert Review of Pharmacoeconomics & Outcomes Research (2013) 13 :277
  • Genetic polymorphisms in telomere pathway genes, telomere length, and breast cancer survival
    Jing Shen, Marilie D. Gammon, Mary Beth Terry, Patrick T. Bradshaw, Qiao Wang, Susan L. Teitelbaum, Alfred I. Neugut, and Regina M. Santella
    Breast Cancer Research and Treatment (2012) 134 :393
  • Activity of distinct growth factor receptor network components in breast tumors uncovers two biologically relevant subtypes
    Mumtahena Rahman, Shelley M. MacNeil, David F. Jenkins, Gajendra Shrestha, Sydney R. Wyatt, Jasmine A. McQuerry, Stephen R. Piccolo, Laura M. Heiser, Joe W. Gray, W. Evan Johnson, and Andrea H. Bild
    Genome Medicine (2017) 9 :
  • A printed SWCNT electrode modified with polycatechol and lysozyme for capacitive detection of α-lactalbumin
    Amal Raouafi, Amal Rabti, and Noureddine Raouafi
    Microchimica Acta (2017) 184 :4351
  • STK33 overexpression in hypopharyngeal squamous cell carcinoma: possible role in tumorigenesis
    Lingyan Huang, Chen Chen, Guodong Zhang, Yuanrong Ju, Jianzhong Zhang, Haibo Wang, and Jianfeng Li
    BMC Cancer (2015) 15 :
  • How to Identify Patients With Increased Risk of Breast Cancer Relapse?
    Ricardo P. Cruz, José L. Pedrini, Cláudio G. Zettler, Ricardo F. Savaris, and Vanise Grassi
    Applied Immunohistochemistry & Molecular Morphology (2014) 22 :488
  • Possible role of hemichannels in cancer
    Kurt A. Schalper, Daniel Carvajal-Hausdorf, and Mauricio P. Oyarzo
    Frontiers in Physiology (2014) 5 :
  • Clinicopathological and Immunohistochemical Features of Triple Negative Breast Cancer
    Heng Chen, Jinjun Li, and Wei Tan
    Advances in Breast Cancer Research (2017) 06 :93
  • Epigenetic markers of prostate cancer in plasma circulating DNA
    Rene Cortese, Andrew Kwan, Emilie Lalonde, Olga Bryzgunova, Anna Bondar, Ying Wu, Juozas Gordevicius, Mina Park, Gabriel Oh, Zachary Kaminsky, Justina Tverkuviene, Arvydas Laurinavicius, Feliksas Jankevicius, Dorota H.S. Sendorek, Syed Haider, Sun-Chong Wang, Sonata Jarmalaite, Pavel Laktionov, Paul C. Boutros, and Arturas Petronis
    Human Molecular Genetics (2012) 21 :3619
  • Breast Cancer in Women Aged 25 Years and Younger
    Constantine Dimitrakakis, Alexandra Tsigginou, Flora Zagouri, Spyros Marinopoulos, Theodoros N. Sergentanis, Antonis Keramopoulos, Paraskevi Liakou, George C. Zografos, Christos A. Papadimitriou, Meletios-Athanassios Dimopoulos, and Aris Antsaklis
    Obstetrics & Gynecology (2013) 121 :1235
  • Intraductal Therapy of Ductal Carcinoma In Situ: A Presurgery Study
    M. Ellen Mahoney, Eva J. Gordon, Jian Yu Rao, Yusheng Jin, Nola Hylton, and Susan M. Love
    Clinical Breast Cancer (2013) 13 :280
  • Topologically inferring risk-active pathways toward precise cancer classification by directed random walk
    Wei Liu, Chunquan Li, Yanjun Xu, Haixiu Yang, Qianlan Yao, Junwei Han, Desi Shang, Chunlong Zhang, Fei Su, Xiaoxi Li, Yun Xiao, Fan Zhang, Meng Dai, and Xia Li
    Bioinformatics (2013) 29 :2169
  • Molecular pathways and molecular imaging in breast cancer: An update
    Anna Rita Cervino, Marta Burei, Luigi Mansi, and Laura Evangelista
    Nuclear Medicine and Biology (2013) 40 :581
  • Quantitative analysis of breast cancer diagnosis using a probabilistic modelling approach
    Shuo Liu, Jinshu Zeng, Huizhou Gong, Hongqin Yang, Jia Zhai, Yi Cao, Junxiu Liu, Yuling Luo, Yuhua Li, Liam Maguire, and Xuemei Ding
    Computers in Biology and Medicine (2018) 92 :168
  • N w-hydroxy-l-arginine as a novel ethnic specific indicator of estrogen-negative breast cancer
    Srinidi Mohan, Nancy Moua, and Lisa Harding
    Amino Acids (2016) 48 :2693
  • Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma
    Ginette Serrero, Douglas M Hawkins, Binbin Yue, Olga Ioffe, Pablo Bejarano, Jeffrey T Phillips, Jonathan F Head, Robert L Elliott, Katherine R Tkaczuk, Andrew K Godwin, JoEllen Weaver, and Wes E Kim
    Breast Cancer Research (2012) 14 :
  • Assessing the clinical utility of cancer genomic and proteomic data across tumor types
    Yuan Yuan, Eliezer M Van Allen, Larsson Omberg, Nikhil Wagle, Ali Amin-Mansour, Artem Sokolov, Lauren A Byers, Yanxun Xu, Kenneth R Hess, Lixia Diao, Leng Han, Xuelin Huang, Michael S Lawrence, John N Weinstein, Josh M Stuart, Gordon B Mills, Levi A Garraway, Adam A Margolin, Gad Getz, and Han Liang
    Nature Biotechnology (2014) 32 :644
  • The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
    International Journal of Oncology (2013) 42 :1770
  • A Prognosis Classifier for Breast Cancer Based on Conserved Gene Regulation between Mammary Gland Development and Tumorigenesis: A Multiscale Statistical Model
    Yingpu Tian, Baozhen Chen, Pengfei Guan, Yujia Kang, Zhongxian Lu, and Wanjin Hong
    PLoS ONE (2013) 8 :e60131
  • Molecular Classification of Estrogen Receptor-positive/Luminal Breast Cancers
    Felipe C. Geyer, Daniel N. Rodrigues, Britta Weigelt, and Jorge S. Reis-Filho
    Advances In Anatomic Pathology (2012) 19 :39
  • The genomic map of breast cancer: which roads lead to better targeted therapies?
    Justin M Balko, Thomas P Stricker, and Carlos L Arteaga
    Breast Cancer Research (2013) 15 :
  • Predictive Biomarkers in Breast Cancer: Their Value in Neoadjuvant Chemotherapy
    L. Fuksa, S. Micuda, J. Grim, A. Ryska, and H. Hornychova
    Cancer Investigation (2012) 30 :663
  • Mitochondrial DNA Levels in Blood and Tissue Samples from Breast Cancer Patients of Different Stages
    Peng Xia, Hui-Juan Wang, Ting-Ting Geng, Xiao-Jie Xun, Wen-Jing Zhou, Tian-Bo Jin, and Chao Chen
    Asian Pacific Journal of Cancer Prevention (2014) 15 :1339
  • Molecular Classification of Breast Cancer
    Robin L. Jones, Anastasia Constantinidou, and Jorge S. Reis-Filho
    Surgical Pathology Clinics (2012) 5 :701
  • Prognostic Value of CD74 and HLA-DR Expressions in Invasive Ductal Breast Cancer
    Muhittin Yaprak, Gülgün Erdogan, Gulbin Aricic, Barıs Ozcan, Ayhan Mesci, Ayhan Dınckan, Okan Erdogan, and Cumhur Arici
    Advances in Breast Cancer Research (2015) 04 :71
  • Increased Expression of Forkhead Box M1 Is Associated with Aggressive Phenotype and Poor Prognosis in Estrogen Receptor-Positive Breast Cancer
    Hyein Ahn, Jongmin Sim, Rehman Abdul, Min Sung Chung, Seung Sam Paik, Young-Ha Oh, Chan Kum Park, and Kiseok Jang
    Journal of Korean Medical Science (2015) 30 :390
  • Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment
    Anthony J. Apostoli and Laurie Ailles
    Critical Reviews in Clinical Laboratory Sciences (2016) 53 :40
  • Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS)
    Evangelia-Ourania Fourkala, Oleg Blyuss, Helen Field, Richard Gunu, Andy Ryan, Julian Barth, Ian Jacobs, Alexey Zaikin, Anne Dawnay, and Usha Menon
    Steroids (2016) 110 :62
  • Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer
    Linling Ju, Yanping Wang, Qing Xie, Xiukun Xu, Yong Li, Zijun Chen, and Yunsen Li
    Glycobiology (2016) 26 :460
  • Ki-67 and the Chromosome Periphery Compartment in Mitosis
    Daniel G. Booth and William C. Earnshaw
    Trends in Cell Biology (2017) 27 :906
  • Label-free detection of anti-estrogen receptor alpha and its binding with estrogen receptor peptide alpha by terahertz spectroscopy
    Mingliang Li, Tianying Chang, Dongshan Wei, Mingjie Tang, Shihan Yan, Chunlei Du, and Hong-Liang Cui
    RSC Advances (2017) 7 :24338
  • Breast Cancer Molecular Subtypes Defined by ER/PR and HER2 Status: Association with Clinicopathologic Parameters in Ivorian Patients
    Ahoua B Effi, N'guiessan A Aman, Baumaney S Koui, Kouadio D Koffi, Zie C Traore, and Mohamed Kouyate
    Asian Pacific Journal of Cancer Prevention (2016) 17 :1973
  • Cell Cycle Model System for Advancing Cancer Biomarker Research
    Iulia M. Lazar, Ina Hoeschele, Juliana de Morais, and Milagros J. Tenga
    Scientific Reports (2017) 7 :
  • Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified
    Shuling Wang, Weidong Li, Ning Liu, Tongxian Zhang, Han Liu, Junjun Liu, Fen Liu, Wei Zhang, Estifanos P. Gebreamlak, and Yun Niu
    Medical Oncology (2012) 29 :2556
  • Attitudes of patients with metastatic cancer towards research biopsies
    Danielle H. Robinson, Leonid Churilov, Nancy U. Lin, Elgene Lim, and Davinia Seah
    Asia-Pacific Journal of Clinical Oncology (2017) :
  • Heavy metals effect on breast cancer progression
    А. Romaniuk, M. Lyndin, V. Sikora, Y. Lyndina, S. Romaniuk, and K. Sikora
    Journal of Occupational Medicine and Toxicology (2017) 12 :
  • The Reliability of Assessment of Ki-67 Expression on Core Needle Biopsy and the Surgical Specimens of Invasive Breast Cancer: Comparison of Local Pathologists’ Assessment and Central Review
    Yoshio Mizuno, Tsuneo Natori, Naoko Takeda, Junichi Yamada, Hiroaki Abe, Yuko Inoue, Hiroshi Seto, and Kazuhiko Sato
    Journal of Cancer Therapy (2012) 03 :841
  • Individualization of treatment strategies
    Adela Fernández Ortega, Laura Jolis López, Gemma Viñas Villaró, Rafael Villanueva Vázquez, Alicia García Arias, Xavier González Farré, Sonia González Jiménez, Cristina Saura Manich, and Javier Cortés Castán
    Advances in Therapy (2011) 28 :19
  • The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma
    Nastaran Ranjbari and Fakher Rahim
    Medical Hypotheses (2013) 80 :311
  • Magnetic Resonance in the Detection of Breast Cancers of Different Histological Types
    Rebecca M. Mayrhofer, Hsiao Piau Ng, Thomas C. Putti, and Philip W. Kuchel
    Magnetic Resonance Insights (2013) 6 :MRI.S10640
  • Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer
    Troels Bechmann, Rikke Fredslund Andersen, Niels Pallisgaard, Jonna Skov Madsen, Else Maae, Erik Hugger Jakobsen, Anne Marie Bak Jylling, Karina Dahl Steffensen, and Anders Jakobsen
    Journal of Cancer Research and Clinical Oncology (2013) 139 :995
  • Biomarkers for the clinical management of breast cancer: International perspective
    Neill Patani, Lesley-Ann Martin, and Mitch Dowsett
    International Journal of Cancer (2013) 133 :1
  • Potential Biomarkers in the Sera of Breast Cancer Patients from Bahawalpur, Pakistan
    Faiz-ul-Hassan Nasim, Samina Ejaz, Muhammad Ashraf, Abdul RehmanAsif, Michael Oellerich, Gulzar Ahmad, Gulzar Ahmad Malik, and Attiq-ur-Rehman
    Biomarkers in Cancer (2012) 4 :BIC.S10502
  • Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion
    Mohd W. Nasser, Zahida Qamri, Yadwinder S. Deol, Diane Smith, Konstantin Shilo, Xianghong Zou, Ramesh K. Ganju, and S. K. Batra
    PLoS ONE (2011) 6 :e23901
  • Nanobodies and Antibodies for Duplexed EGFR/HER2 Immunoassays Using Terbium-to-Quantum Dot FRET
    Xue Qiu, K. David Wegner, Yu-Tang Wu, Paul M. P. van Bergen en Henegouwen, Travis L. Jennings, and Niko Hildebrandt
    Chemistry of Materials (2016) 28 :8256
  • Classifying Ten Types of Major Cancers Based on Reverse Phase Protein Array Profiles
    Pei-Wei Zhang, Lei Chen, Tao Huang, Ning Zhang, Xiang-Yin Kong, Yu-Dong Cai, and Lukasz Kurgan
    PLOS ONE (2015) 10 :e0123147
  • Breast cancer diagnosis: Imaging techniques and biochemical markers
    Seyed Hamed Jafari, Zahra Saadatpour, Arash Salmaninejad, Fatemeh Momeni, Mojgan Mokhtari, Javid Sadri Nahand, Majid Rahmati, Hamed Mirzaei, and Mojtaba Kianmehr
    Journal of Cellular Physiology (2018) :
  • α-Santalol, A Skin Cancer Chemopreventive Agent with Potential to Target Various Pathways Involved in Photocarcinogenesis
    Sreevidya Santha and Chandradhar Dwivedi
    Photochemistry and Photobiology (2013) 89 :919
  • Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
    G. P. Burrai, A. Tanca, M. R. De Miglio, M. Abbondio, S. Pisanu, M. Polinas, S. Pirino, S. I. Mohammed, S. Uzzau, M. F. Addis, and E. Antuofermo
    Tumor Biology (2015) 36 :9083
  • Tissue and Soluble Biomarkers in Breast Cancer and Their Applications: Ready to Use?
    M. Danova, S. Delfanti, M. Manzoni, and S. Mariucci
    JNCI Monographs (2011) 2011 :75
  • Analysis of breast cancer-associated glycosphingolipids using electrospray ionization-linear ion trap quadrupole mass spectrometry
    Tingting Zhu, Longjiang Xu, Xiukun Xu, Zheng Wang, Jian Zhu, Qing Xie, Biyan Zhang, Yanping Wang, Linling Ju, Yun He, Xinshan Ye, Dapeng Zhou, and Yunsen Li
    Carbohydrate Research (2015) 402 :189
  • HBXIP expression predicts patient prognosis in breast cancer
    Daye Cheng, Bin Liang, and Yunhui Li
    Medical Oncology (2014) 31 :
  • Synthesis and preliminary evaluation of a18F-labeled ethisterone derivative [18F]EAEF for progesterone receptor targeting
    Xiaowei Wu, Linyi You, Deliang Zhang, Mengna Gao, Zijing Li, Duo Xu, Pu Zhang, Lumei Huang, Rongqiang Zhuang, Hua Wu, and Xianzhong Zhang
    Chemical Biology & Drug Design (2017) 89 :559
  • Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients
    Eva Jezkova, Pavol Zubor, Karol Kajo, Marian Grendar, Karol Dokus, Marian Adamkov, Zora Lasabova, Lukas Plank, and Jan Danko
    Oncology Letters (2017) 14 :758
  • Improving biomarker list stability by integration of biological knowledge in the learning process
    Tiziana Sanavia, Fabio Aiolli, Giovanni Da San Martino, Andrea Bisognin, and Barbara Di Camillo
    BMC Bioinformatics (2012) 13 :S22
  • Histone H1 Phosphorylation in Breast Cancer
    Sean W. Harshman, Michael E. Hoover, Chengsi Huang, Owen E. Branson, Sarah B. Chaney, Carolyn M. Cheney, Thomas J. Rosol, Charles L. Shapiro, Vicki H. Wysocki, Kay Huebner, and Michael A. Freitas
    Journal of Proteome Research (2014) 13 :2453
  • Real-time quantitative RT-PCR detection of circulating tumor cells from breast cancer patients
    International Journal of Oncology (2015) 46 :281
  • Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma
    Νiki Ι. Chantzi, Dina G. Tiniakos, Marina Palaiologou, Nikolaos Goutas, Theodoros Filippidis, Stamatis D. Vassilaros, Eugen Dhimolea, Dimitra J. Mitsiou, and Μichael N. Alexis
    Journal of Cancer Research and Clinical Oncology (2013) 139 :1489
  • Current role and safety profile of aromatase inhibitors in early breast cancer
    Federica Tomao, GianPaolo Spinelli, Patrizia Vici, Giovanni Codacci Pisanelli, GianLuca Cascialli, Luigi Frati, PierLuigi Benedetti Panici, and Silverio Tomao
    Expert Review of Anticancer Therapy (2011) 11 :1253
  • Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers
    Yi-Wei Wang, Mei-Ling Zhu, Rui-Fen Wang, Wen-Ji Xue, Xue-Ru Zhu, Li-Feng Wang, and Lei-Zhen Zheng
    Tumor Biology (2016) 37 :8567
  • The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression
    Li Bie, Gang Zhao, Pui Cheng, Gaelle Rondeau, Steffen Porwollik, Yan Ju, Xiao-Qin Xia, Michael McClelland, and Michael Lim
    PLoS ONE (2011) 6 :e25631
  • TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome
    Mohammed A. Aleskandarany, Ola H. Negm, Emad A. Rakha, Mohamed A. H. Ahmed, Christopher C. Nolan, Graham R. Ball, Carlos Caldas, Andrew R. Green, Patrick J. Tighe, and Ian O. Ellis
    Breast Cancer Research and Treatment (2012) 136 :419
  • The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis
    Siwanon Jirawatnotai, Samanta Sharma, Wojciech Michowski, Bhoom Suktitipat, Yan Geng, John Quackenbush, Joshua E Elias, Steven P Gygi, Yaoyu E Wang, and Piotr Sicinski
    Cell Cycle (2014) 13 :2889
  • Breast Cancer Incidence in Black and White Women Stratified by Estrogen and Progesterone Receptor Statuses
    Michael X. Gleason, Tengiz Mdzinarishvili, Simon Sherman, and Virginia J. Vitzthum
    PLoS ONE (2012) 7 :e49359
  • CEST-Dixon for human breast lesion characterization at 3 T: A preliminary study
    Shu Zhang, Stephen Seiler, Xinzeng Wang, Ananth J. Madhuranthakam, Jochen Keupp, Emily E. Knippa, Robert E. Lenkinski, and Elena Vinogradov
    Magnetic Resonance in Medicine (2018) :
  • A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
    Abeer M. Shaaban, Graham R. Ball, Rebecca A. Brannan, Gabor Cserni, Anna Di Benedetto, Jo Dent, Laura Fulford, Helen Honarpisheh, Lee Jordan, J. Louise Jones, Rani Kanthan, Loaie Maraqa, Maria Litwiniuk, Marcella Mottolese, Steven Pollock, Elena Provenzano, Philip R. Quinlan, Georgina Reall, Sami Shousha, Mark Stephens, Eldo T. Verghese, Rosemary A. Walker, Andrew M. Hanby, and Valerie Speirs
    Breast Cancer Research and Treatment (2012) 133 :949
  • A 14-Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic Melanoma
    Erin K. Sykes, Cassandra E. McDonald, Shila Ghazanfar, Swetlana Mactier, John F. Thompson, Richard A. Scolyer, Jean Y. Yang, Graham J. Mann, and Richard I. Christopherson
    PROTEOMICS - Clinical Applications (2018) :1700094
  • The role of biomarkers in the choice of therapy in breast cancer
    Brigitte Mlineritsch, Sigrun Ressler, and Richard Greil
    memo - Magazine of European Medical Oncology (2012) 5 :101
  • Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients
    Samina Ejaz, Faiz-ul-Hassan Nasim, Muhammad Ashraf, and Gulzar Ahmad
    Heliyon (2017) 3 :e00356
  • Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers
    S. J. Kim, S. Nakayama, K. Shimazu, Y. Tamaki, K. Akazawa, F. Tsukamoto, Y. Torikoshi, T. Matsushima, M. Shibayama, H. Ishihara, and S. Noguchi
    Annals of Oncology (2012) 23 :891
  • Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors
    Hao Wang, Ping Chen, Xin-Xin Liu, Wei Zhao, Lei Shi, Xue-Wen Gu, Chang-Ren Zhu, Hai-Hang Zhu, and Liang Zong
    World Journal of Surgical Oncology (2014) 12 :89
  • Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
    Hongjiang Wang, Guang Tan, Lei Dong, Lei Cheng, Kejun Li, Zhongyu Wang, Haifeng Luo, and William C. S. Cho
    PLoS ONE (2012) 7 :e34210
  • The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy
    Seung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, Hideo Inaji, Futoshi Akiyama, Hiroshi Sonoo, Junichi Kurebayashi, Katsuhide Yoshidome, Masahiko Tsujimoto, Hiroyuki Takei, Shinobu Masuda, Seigo Nakamura, and Shinzaburo Noguchi
    Cancer Letters (2014) 355 :217
  • Patient attitudes towards undergoing additional breast biopsy for research
    Farhan Naim, Rachel Ballinger, Ines Rombach, Dimitri J. Hadjiminas, Ragheed Al-Mufti, Rosalyn K. Hogben, Ruth McLauchlan, Carlo Palmieri, and Susan J. Cleator
    The Breast (2013) 22 :850
  • Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2−, triple positive and triple-negative breast cancer patients
    International Journal of Oncology (2014) 45 :2549
  • Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients
    Atif Ali Hashmi, Saher Aijaz, Saadia Mehmood Khan, Raeesa Mahboob, Muhammad Irfan, Narisa Iftikhar Zafar, Mariam Nisar, Maham Siddiqui, Muhammad Muzzammil Edhi, Naveen Faridi, and Amir Khan
    World Journal of Surgical Oncology (2018) 16 :
  • Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy
    Jun Wang, Dali Li, Baocheng Wang, and Yun Wu
    Breast Cancer Research and Treatment (2013) 141 :213
  • Gene expression profiling of breast cancer in Lebanese women
    Joelle Makoukji, Nadine J. Makhoul, Maya Khalil, Sally El-Sitt, Ehab Saad Aldin, Mark Jabbour, Fouad Boulos, Emanuela Gadaleta, Ajanthah Sangaralingam, Claude Chelala, Rose-Mary Boustany, and Arafat Tfayli
    Scientific Reports (2016) 6 :
  • High-throughput automated scoring of Ki67 in breast cancer tissue microarrays from the Breast Cancer Association Consortium
    Mustapha Abubakar, William J Howat, Frances Daley, Lila Zabaglo, Leigh-Anne McDuffus, Fiona Blows, Penny Coulson, H Raza Ali, Javier Benitez, Roger Milne, Herman Brenner, Christa Stegmaier, Arto Mannermaa, Jenny Chang-Claude, Anja Rudolph, Peter Sinn, Fergus J Couch, Rob A.E.M. Tollenaar, Peter Devilee, Jonine Figueroa, Mark E Sherman, Jolanta Lissowska, Stephen Hewitt, Diana Eccles, Maartje J Hooning, Antoinette Hollestelle, John WM Martens, Carolien HM van Deurzen, kConFab Investigators, Manjeet K Bolla, Qin Wang, Michael Jones, Minouk Schoemaker, Annegien Broeks, Flora E van Leeuwen, Laura Van't Veer, Anthony J Swerdlow, Nick Orr, Mitch Dowsett, Douglas Easton, Marjanka K Schmidt, Paul D Pharoah, and Montserrat Garcia-Closas
    The Journal of Pathology: Clinical Research (2016) 2 :138
  • Gradually implemented new biomarkers for prognostication of breast cancer: complete case analysis may introduce bias
    Nirmala Bhoo Pathy, Cuno S.P.M. Uiterwaal, Nur Aishah Taib, Helena M. Verkooijen, and Cheng Har Yip
    Journal of Clinical Epidemiology (2012) 65 :568
  • Development of a label-free gold nanoparticle-based colorimetric aptasensor for detection of human estrogen receptor alpha
    Rajesh Ahirwar and Pradip Nahar
    Analytical and Bioanalytical Chemistry (2016) 408 :327
  • The role of functional data in interpreting the effects of genetic variation
    D. L. Young and S. Fields
    Molecular Biology of the Cell (2015) 26 :3904
  • Modulatory effect of neoadjuvant chemotherapy on biomarkers expression; assessment by digital image analysis and relationship to residual cancer burden in patients with invasive breast cancer
    Amber Cockburn, Jingsheng Yan, Dewi Rahardja, David Euhus, Yan Peng, Yisheng Fang, and Venetia Rumnong Sarode
    Human Pathology (2014) 45 :249
  • Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF-κB signaling pathways in vitro
    Juan Luo, Yan-Ling Hu, and Hong Wang
    Experimental and Therapeutic Medicine (2017) 14 :3623
  • Frequent Alterations of MCPH1 and ATM are Associated with Primary Breast Carcinoma: Clinical and Prognostic Implications
    Nilanjana Bhattacharya, Nupur Mukherjee, Ratnesh K. Singh, Satyabrata Sinha, Neyaz Alam, Anup Roy, Susanta Roychoudhury, and Chinmay Kumar Panda
    Annals of Surgical Oncology (2013) 20 :424
  • Breast cancer prognosis predicted by nuclear receptor-coregulator networks
    Tram B. Doan, Natalie A. Eriksson, Dinny Graham, John W. Funder, Evan R. Simpson, Elizabeth S. Kuczek, Colin Clyne, Peter J. Leedman, Wayne D. Tilley, Peter J. Fuller, George E.O. Muscat, and Christine L. Clarke
    Molecular Oncology (2014) 8 :998
  • Systematic investigation of Amphioxus (Branchiostoma floridae) microRNAs
    Xue Zhou, Ping Jin, Sheng Qin, Liming Chen, and Fei Ma
    Gene (2012) 508 :110
  • Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis
    Stylianos Serghiou, Aikaterini Kyriakopoulou, and John P. A. Ioannidis
    Molecular Cancer (2016) 15 :
  • HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: A review
    Constance Thibault, Wassim Khodari, Marie Lequoy, Joseph Gligorov, and Yazid Belkacémi
    Critical Reviews in Oncology/Hematology (2013) 88 :123
  • Modern methods in breast cancer diagnostics
    S. N. Tamkovich, V. E. Voytsitskiy, and P. P. Laktionov
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry (2014) 8 :302
  • Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids
    Kathrin Halfter, Oliver Hoffmann, Nina Ditsch, Mareike Ahne, Frank Arnold, Stefan Paepke, Dieter Grab, Ingo Bauerfeind, and Barbara Mayer
    Journal of Translational Medicine (2016) 14 :
  • The expression and clinical significance of melanoma-associated antigen-A1, -A3 and -A11 in glioma
    Oncology Letters (2013) 6 :55
  • Expression of activator protein-1 (AP-1) family members in breast cancer
    Amirhossein Kharman-Biz, Hui Gao, Reza Ghiasvand, Chunyan Zhao, Kazem Zendehdel, and Karin Dahlman-Wright
    BMC Cancer (2013) 13 :
  • Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer
    Máire-Caitlín Casey, Karl J. Sweeney, James Andrew Lawrence Brown, and Michael J. Kerin
    International Journal of Cancer (2016) 139 :12
  • Retrospective Proteomic Screening of 100 Breast Cancer Tissues
    Ida Pucci-Minafra, Gianluca Di Cara, Rosa Musso, Patrizia Cancemi, Nadia Albanese, Elena Roz, and Salvatore Minafra
    Proteomes (2017) 5 :15
  • Reconsideration of Clinical and Histopathological Prognostic Factors in Breast Cancer Patients: A Single Center Experience
    Ozgur Tanriverdi, Nezih Meydan, and Sabri Barutca
    Asian Pacific Journal of Cancer Prevention (2014) 15 :807
  • Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study
    Nirmala Pathmanathan, Jing-shu Geng, Wencai Li, Xiu Nie, Januario Veloso, Julie Hill, Philip McCloud, and Michael Bilous
    Asia-Pacific Journal of Clinical Oncology (2016) 12 :369
  • Molecular Diagnostic Testing in Breast Cancer
    Brygida Berse and Julie A. Lynch
    Seminars in Oncology Nursing (2015) 31 :108
  • Estrogen Receptor-Targeted Contrast Agents for Molecular Magnetic Resonance Imaging of Breast Cancer Hormonal Status
    Adi Pais and Hadassa Degani
    Frontiers in Oncology (2016) 6 :
  • Cancer molecular markers: A guide to cancer detection and management
    Meera Nair, Sardul Singh Sandhu, and Anil Kumar Sharma
    Seminars in Cancer Biology (2018) :
  • Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer
    Xiangyan Ruan, Ying Zhang, Alfred O. Mueck, Marina Willibald, Harald Seeger, Tanja Fehm, Sara Brucker, and Hans Neubauer
    Menopause (2017) 24 :203
  • Prolifération des cancers du sein et biomarqueurs décisionnels en pratique RPC (RPC 2013)
    F. André, S. Delaloge, J. -M. Guinebretière, T. Petit, J. -Y. Pierga, D. Zarca, and K. Zarca
    Oncologie (2013) 15 :594
  • Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells
    I Moy, V Todorović, A D Dubash, J S Coon, J B Parker, M Buranapramest, C C Huang, H Zhao, K J Green, and S E Bulun
    Oncogene (2015) 34 :323
  • Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer
    A. S. Noman, M. Uddin, A. A. Chowdhury, M. J. Nayeem, Z. Raihan, M. I. Rashid, A. K. Azad, M. L. Rahman, D. Barua, A. Sultana, A. Shirin, J. Ferdous, R. R. Parag, S. M. Rahman, M. R. Mahmud, C. S. Jerin, N. Jahan, A. Siddiqua, T. Ara, E. B. Sabur, S. S. Alam, S. Baidya, S. Akther, M. Z. Rahman, T. Banu, A. K. Murugan, S. Sabri, S. M. S. Islam, B. Karakas, A. Aboussekhra, H. Yeger, W. A. Farhat, and S. S. Islam
    Scientific Reports (2017) 7 :
  • Label-free identification and characterization of living human primary and secondary tumour cells
    Dimitrios Tsikritsis, Susanna Richmond, Patrick Stewart, Alistair Elfick, and Andrew Downes
    The Analyst (2015) 140 :5162
  • Biomarkers in cancer: is ‘omices’ the way to go
    Libyan Journal of Medicine (2011) 6 :5982
  • Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications
    FL Queiroga, D Pérez-Alenza, A González-Gil, G Silván, L Peña, and JC Illera
    Reproduction in Domestic Animals (2015) 50 :858
  • ZDHHC3 as a Risk and Mortality Marker for Breast Cancer in African American Women
    Nick Kinney, Robin T Varghese, Ramu Anandakrishnan, and Harold R “Skip” Garner
    Cancer Informatics (2017) 16 :117693511774664
  • Side Population Cell Level in Human Breast Cancer and Factors Related to Disease-free Survival
    C.G. Jin, T.N. Zou, J. Li, X.Q. Chen, X. Liu, Y.Y. Wang, X. Wang, Y.H. Che, X.C. Wang, and Hutcha Sriplung
    Asian Pacific Journal of Cancer Prevention (2015) 16 :991
  • Aptamer-Assisted Detection of the Altered Expression of Estrogen Receptor Alpha in Human Breast Cancer
    Rajesh Ahirwar, Shamsudheen Karuthedath Vellarikkal, Arghya Sett, Sridhar Sivasubbu, Vinod Scaria, Utpal Bora, Bibhuti Bhusan Borthakur, Amal Chandra Kataki, Jagannath Dev Sharma, Pradip Nahar, and Wei Xu
    PLOS ONE (2016) 11 :e0153001
  • The Prognostic Importance of Nuclear Factor κB and Hypoxia-inducible Factor 1α in Relation to the Breast Cancer Subtype and the Overall Survival
    Koraljka Rajković-Molek, Elvira Mustać, Ita Hadžisejdić, and Nives Jonjić
    Applied Immunohistochemistry & Molecular Morphology (2014) 22 :464
  • Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression
    John Castle, Karen Morris, Susan Pritchard, Cliona C. Kirwan, and Jeffrey Chalmers
    PLOS ONE (2017) 12 :e0175647
  • A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer
    Wolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, Joanna Pikiel, Elzbieta Staroslawska, Piotr Potemski, Christoph Salat, Etienne Brain, Christian Caglevic, Kathryn Briggs, Michelle DeSilvio, Luca Marini, and Christos Papadimitriou
    Breast Cancer Research and Treatment (2014) 143 :493
  • Glycoprotein Profiles of Human Breast Cells Demonstrate a Clear Clustering of Normal/Benign versus Malignant Cell Lines and Basal versus Luminal Cell Lines
    Ten-Yang Yen, Bruce A. Macher, Claudia A. McDonald, Chris Alleyne-Chin, and Leslie C. Timpe
    Journal of Proteome Research (2012) 11 :656
  • Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study
    Paraskevi Panagopoulou, Helen Gogas, Nick Dessypris, Nikos Maniadakis, George Fountzilas, and Eleni Th. Petridou
    European Journal of Epidemiology (2012) 27 :857
  • Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells
    Regina Ebert, Sabine Zeck, Jutta Meissner-Weigl, Barbara Klotz, Tilman D. Rachner, Peggy Benad, Ludger Klein-Hitpass, Maximilian Rudert, Lorenz C. Hofbauer, and Franz Jakob
    Bone (2012) 50 :723
  • Intratumoral regulatory T cells as an independent predictive factor for pathological complete response to neoadjuvant paclitaxel followed by 5-FU/epirubicin/cyclophosphamide in breast cancer patients
    Naofumi Oda, Kenzo Shimazu, Yasuto Naoi, Koji Morimoto, Atsushi Shimomura, Masashi Shimoda, Naofumi Kagara, Naomi Maruyama, Seung Jin Kim, and Shinzaburo Noguchi
    Breast Cancer Research and Treatment (2012) 136 :107
  • Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment
    Huizhe Wu, Shu Guan, Mingli Sun, Zhaojin Yu, Lin Zhao, Miao He, Haishan Zhao, Weifan Yao, Enhua Wang, Feng Jin, Qinghuan Xiao, Minjie Wei, and Yves St-Pierre
    PLOS ONE (2015) 10 :e0126128
  • Cancer biomarker discovery: Current status and future perspectives
    Katrin Mäbert, Monica Cojoc, Claudia Peitzsch, Ina Kurth, Serhiy Souchelnytskyi, and Anna Dubrovska
    International Journal of Radiation Biology (2014) 90 :659
  • Identification of prognostic signature in cancer based on DNA methylation interaction network
    Wei-Lin Hu and Xiong-Hui Zhou
    BMC Medical Genomics (2017) 10 :
  • Membrane Progesterone Receptor Alpha as a Potential Prognostic Biomarker for Breast Cancer Survival: A Retrospective Study
    Mingxuan Xie, Xiangzhu Zhu, Zhaofan Liu, Martha Shrubsole, Vijay Varma, Ingrid A. Mayer, Qi Dai, Qiong Chen, Shaojin You, and Jin Q. Cheng
    PLoS ONE (2012) 7 :e35198
  • Dynamic 18 F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts
    Alexandr Kristian, Line B. Nilsen, Kathrine Røe, Mona-Elisabeth Revheim, Olav Engebråten, Gunhild M. Mælandsmo, Ruth Holm, Eirik Malinen, and Therese Seierstad
    Nuclear Medicine and Molecular Imaging (2013) 47 :173
  • Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival
    Kleita Michaelidou, Alexandros Ardavanis, and Andreas Scorilas
    Breast Cancer Research and Treatment (2015) 152 :323
  • Hide and seek: tell-tale signs of breast cancer lurking in the blood
    David S. Guttery, Kevin Blighe, Karen Page, Stephanie D. Marchese, Allison Hills, R. Charles Coombes, Justin Stebbing, and Jacqueline A. Shaw
    Cancer and Metastasis Reviews (2013) 32 :289
  • Activation of rapid oestrogen signalling in aggressive human breast cancers
    Coralie Poulard, Isabelle Treilleux, Emilie Lavergne, Katia Bouchekioua-Bouzaghou, Sophie Goddard-Léon, Sylvie Chabaud, Olivier Trédan, Laura Corbo, and Muriel Le Romancer
    EMBO Molecular Medicine (2012) 4 :1200
  • Robust method for identification of prognostic gene signatures from gene expression profiles
    Woogwang Sim, Jungsul Lee, and Chulhee Choi
    Scientific Reports (2017) 7 :
  • Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer
    D K Woolf, M Beresford, S P Li, M Dowsett, B Sanghera, W L Wong, L Sonoda, S Detre, V Amin, M-L Ah-See, D Miles, and A Makris
    British Journal of Cancer (2014) 110 :2847
  • Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas
    Spyros S Skandalis, Vassiliki T Labropoulou, Panagiota Ravazoula, Eleni Likaki-Karatza, Katalin Dobra, Haralabos P Kalofonos, Nikos K Karamanos, and Achilleas D Theocharis
    BMC Cancer (2011) 11 :
  • Detection and Segmentation of Cell Nuclei in Virtual Microscopy Images: A Minimum-Model Approach
    Stephan Wienert, Daniel Heim, Kai Saeger, Albrecht Stenzinger, Michael Beil, Peter Hufnagl, Manfred Dietel, Carsten Denkert, and Frederick Klauschen
    Scientific Reports (2012) 2 :
  • Identification of novel micrornas inXenopus laevismetaphase ii arrested eggs
    Sakthikumar Ambady, Zheyang Wu, and Tanja Dominko
    genesis (2012) 50 :286
  • Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program
    Sonya Das and Andrew W. Lo
    Contemporary Clinical Trials (2017) 62 :168
  • BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy
    A. S. Hamy, I. Bieche, J. Lehmann-Che, V. Scott, Ph. Bertheau, J. M. Guinebretière, M. C. Matthieu, B. Sigal-Zafrani, O. Tembo, M. Marty, B. Asselain, F. Spyratos, and P. de Cremoux
    Breast Cancer Research and Treatment (2016) 159 :499
  • Frequent alterations ofLOH11CR2A, PIG8andCHEK1genes at chromosomal 11q24.1-24.2 region in breast carcinoma: Clinical and prognostic implications
    Satyabrata Sinha, Ratnesh K. Singh, Nilanjana Bhattacharya, Nupur Mukherjee, Susmita Ghosh, Neyaz Alam, Anup Roy, Susanta Roychoudhury, and Chinmay Kumar Panda
    Molecular Oncology (2011) 5 :454
  • The prognostic value of apoptotic and proliferative markers in breast cancer
    Charla C. Engels, Francesca Ruberta, Esther M. de Kruijf, Gabi W. van Pelt, Vincent T. H. B. M. Smit, Gerrit Jan Liefers, Tomoko Matsushima, Masaki Shibayama, Hideki Ishihara, Cornelis J. H. van de Velde, and Peter J. K. Kuppen
    Breast Cancer Research and Treatment (2013) 142 :323
  • Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers
    Ying Dunkel, Kexin Diao, Nicolas Aznar, Lee Swanson, Lawrence Liu, Wenhong Zhu, Xiao-yi Mi, and Pradipta Ghosh
    The FASEB Journal (2016) 30 :3702
  • RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
    C. Denkert, S. Loibl, R. Kronenwett, J. Budczies, C. von Torne, V. Nekljudova, S. Darb-Esfahani, C. Solbach, B. V. Sinn, C. Petry, B. M. Muller, J. Hilfrich, G. Altmann, A. Staebler, C. Roth, B. Ataseven, T. Kirchner, M. Dietel, M. Untch, and G. von Minckwitz
    Annals of Oncology (2013) 24 :632
  • Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer
    Olivia Jane Scully, Yingnan Yu, Agus Salim, Aye Aye Thike, George Wai-Cheong Yip, Gyeong Hun Baeg, Puay-Hoon Tan, Ken Matsumoto, and Boon Huat Bay
    Experimental Biology and Medicine (2015) 240 :846
  • Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
    Elisabeth Luporsi, Fabrice André, Frédérique Spyratos, Pierre-Marie Martin, Jocelyne Jacquemier, Frédérique Penault-Llorca, Nicole Tubiana-Mathieu, Brigitte Sigal-Zafrani, Laurent Arnould, Anne Gompel, Caroline Egele, Bruno Poulet, Krishna B. Clough, Hubert Crouet, Alain Fourquet, Jean-Pierre Lefranc, Carole Mathelin, Nicolas Rouyer, Daniel Serin, Marc Spielmann, Margaret Haugh, Marie-Pierre Chenard, Etienne Brain, Patricia de Cremoux, and Jean-Pierre Bellocq
    Breast Cancer Research and Treatment (2012) 132 :895
  • Prognostic markers in stage I oral cavity squamous cell carcinoma
    Johannes Dunkel, Samuli Vaittinen, Reidar Grénman, Ilpo Kinnunen, and Heikki Irjala
    The Laryngoscope (2013) :n/a
  • Quantitative Progesterone Receptor Expression and Efficacy of Anti-estrogen Therapy in Breast Cancer
    Shiuh-Wen Luoh, Betsy Ramsey, Byung Park, and Edward Keenan
    The Breast Journal (2014) 20 :46
  • Functional coupling of transcription factor HiNF-P and histone H4 gene expression during pre- and post-natal mouse development
    Li-Jun Liu, Ronglin Xie, Sadiq Hussain, Jane B. Lian, Jaime Rivera-Perez, Stephen N. Jones, Janet L. Stein, Gary S. Stein, and Andre J. van Wijnen
    Gene (2011) 483 :1
  • Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer
    Hiroji Iwata, Norikazu Masuda, Yasuaki Sagara, Takayuki Kinoshita, Seigo Nakamura, Yasuhiro Yanagita, Reiki Nishimura, Hirotaka Iwase, Shunji Kamigaki, Hiroyuki Takei, Hitoshi Tsuda, Nobuya Hayashi, and Shinzaburo Noguchi
    Cancer (2013) 119 :704
  • How useful are molecular assays in breast cancer in the elderly?
    Nigel J Bundred
    Aging Health (2013) 9 :291
  • Next generation of microbiological risk assessment: Potential of omics data for exposure assessment
    Heidy M.W. den Besten, Alejandro Amézquita, Sara Bover-Cid, Stéphane Dagnas, Mariem Ellouze, Sandrine Guillou, George Nychas, Cian O'Mahony, Fernando Pérez-Rodriguez, and Jeanne-Marie Membré
    International Journal of Food Microbiology (2017) :
  • Expression of microRNA-497 and its prognostic significance in human breast cancer
    Shaohua Wang, Hanjun Li, Jingjie Wang, and Dan Wang
    Diagnostic Pathology (2013) 8 :172
  • Progesterone and Src Family Inhibitor PP1 Synergistically Inhibit Cell Migration and Invasion of Human Basal Phenotype Breast Cancer Cells
    Mingxuan Xie, Li Zhou, Xi Chen, Lindsey O. Gainey, Jian Xiao, Mark S. Nanes, Anji Hou, Shaojin You, and Qiong Chen
    BioMed Research International (2015) 2015 :1
  • Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
    Ana Barradas and Leon Terstappen
    Cancers (2013) 5 :1619
  • Carcinoma of the mammary gland in a mare
    L. Bussche, C. Harms, E. L. Buckles, D. Whelchel, M. Brosnahan, and G. R. Van de Walle
    Equine Veterinary Education (2017) 29 :370
  • In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules
    Rajesh Ahirwar, Smita Nahar, Shikha Aggarwal, Srinivasan Ramachandran, Souvik Maiti, and Pradip Nahar
    Scientific Reports (2016) 6 :
  • Genome-Wide Transcript Profiling Reveals Novel Breast Cancer-Associated Intronic Sense RNAs
    Sang Woo Kim, Elane Fishilevich, Gustavo Arango-Argoty, Yuefeng Lin, Guodong Liu, Zhihua Li, A. Paula Monaghan, Mark Nichols, Bino John, and Rajeev Samant
    PLOS ONE (2015) 10 :e0120296
  • Small breast epithelial mucin tumor tissue expression is associated with increased risk of recurrence and death in triple-negative breast cancer patients
    Liang Liu, Zhaozhe Liu, Shuxian Qu, Zhendong Zheng, Yongye Liu, Xiaodong Xie, and Fulin Song
    Diagnostic Pathology (2013) 8 :
  • Segmentation of cell nuclei in heterogeneous microscopy images: A reshapable templates approach
    Mehdi Alilou, Vassili Kovalev, and Vahid Taimouri
    Computerized Medical Imaging and Graphics (2013) 37 :488
  • miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer
    Katarzyna Augoff, Brian McCue, Edward F Plow, and Khalid Sossey-Alaoui
    Molecular Cancer (2012) 11 :5
  • Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women
    Benedito de Sousa Almeida-Filho, Heloisa De Luca Vespoli, Eduardo Carvalho Pessoa, Murilo Machado, Jorge Nahas-Neto, and Eliana Aguiar Petri Nahas
    The Journal of Steroid Biochemistry and Molecular Biology (2017) 174 :284
  • SLP-2 overexpression could serve as a prognostic factor in node positive and HER2 negative breast cancer
    Wenfeng Cao, Bin Zhang, Jin Li, Yanxue Liu, Zhihua Liu, and Baocun Sun
    Pathology (2011) 43 :713
  • MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients’ Samples
    Alessio Cannistraci, Anna Laura Di Pace, Ruggero De Maria, and Désirée Bonci
    BioMed Research International (2014) 2014 :1
  • Integrative analysis of survival-associated gene sets in breast cancer
    Frederick S Varn, Matthew H Ung, Shao Ke Lou, and Chao Cheng
    BMC Medical Genomics (2015) 8 :
  • Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women
    E.-O. Fourkala, A. Zaikin, M. Burnell, A. Gentry-Maharaj, J. Ford, R. Gunu, C. Soromani, G. Hasenbrink, I. Jacobs, A. Dawnay, M. Widschwendter, H. Lichtenberg-Frate, and U. Menon
    Endocrine Related Cancer (2012) 19 :137
  • Highly sensitive detection of cancer cells using femtosecond dual-wavelength near-IR two-photon imaging
    Jean R. Starkey, Nikolay S. Makarov, Mikhail Drobizhev, and Aleksander Rebane
    Biomedical Optics Express (2012) 3 :1534
  • Controlled Three-Dimensional Tumor Microenvironments Recapitulate Phenotypic Features and Differential Drug Response in Early vs Advanced Stage Breast Cancer
    Manjulata Singh, Harini Venkata Krishnan, Supraja Ranganathan, Brian Kiesel, Jan Hendrik Beumer, Sreeja Sreekumar, and Shilpa Sant
    ACS Biomaterials Science & Engineering (2018) 4 :421
  • Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm
    Wataru Mizunoya, Ritika Upadhaya, Frank J. Burczynski, Guqi Wang, and Judy E. Anderson
    American Journal of Physiology-Cell Physiology (2011) 300 :C1065
  • Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan
    Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, and Masakazu Toi
    Breast Cancer Research and Treatment (2012) 133 :759
  • Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples
    Tonje Haukaas, Leslie Euceda, Guro Giskeødegård, and Tone Bathen
    Metabolites (2017) 7 :18
  • Ki67 chez les patientes jeunes présentant un cancer du sein
    F. Vasseur, M.-C. Baranzelli, C. Fournier, and J. Bonneterre
    Gynécologie Obstétrique & Fertilité (2013) 41 :16
  • LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer
    Yi Shen, Zhanwei Wang, Lenora WM Loo, Yan Ni, Wei Jia, Peiwen Fei, Harvey A. Risch, Dionyssios Katsaros, and Herbert Yu
    Breast Cancer Research and Treatment (2015) 154 :473
  • Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies
    Franklin L. Nobrega, Débora Ferreira, Ivone M. Martins, Maria Suarez-Diez, Joana Azeredo, Leon D. Kluskens, and Lígia R. Rodrigues
    BMC Cancer (2016) 16 :
  • Challenges translating breast cancer gene signatures into the clinic
    Britta Weigelt, Lajos Pusztai, Alan Ashworth, and Jorge S. Reis-Filho
    Nature Reviews Clinical Oncology (2012) 9 :58
  • Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts
    Alexandr Kristian, Jon Erik Holtedahl, Turid Torheim, Cecilia Futsaether, Eivor Hernes, Olav Engebraaten, Gunhild M. Mælandsmo, and Eirik Malinen
    Molecular Imaging and Biology (2017) 19 :271
  • Comparative study of Her-2, p53, Ki-67 expression and clinicopathological characteristics of breast cancer in a cohort of northern China female patients
    Li Ding, Zijin Zhang, Yan Xu, and Yongqiang Zhang
    Bioengineered (2017) 8 :383
  • Predictable Factors for Lymph Node Metastasis in Early Gastric Cancer—Analysis of Single Institutional Experience
    Man Sup Lim, Hae-Wan Lee, Hyoungjune Im, Byung Seup Kim, Mi Yeol Lee, Jang Yong Jeon, Dae Hyun Yang, and Bong Hwa Lee
    Journal of Gastrointestinal Surgery (2011) 15 :1783
  • Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies
    Sunil Mittal, Hardeep Kaur, Nandini Gautam, and Anil K. Mantha
    Biosensors and Bioelectronics (2017) 88 :217
  • A novel model for Ki67 assessment in breast cancer
    Quinci Romero, Pär-Ola Bendahl, Mårten Fernö, Dorthe Grabau, and Signe Borgquist
    Diagnostic Pathology (2014) 9 :118
  • Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies
    Ijeoma Adaku Umelo, Brunella Costanza, and Vincent Castronovo
    Cancer and Metastasis Reviews (2018) 37 :125
  • Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
    Kyongchol Kim, Dong Gue Shin, Min Koo Park, Seung Hyuk Baik, Tae Hee Kim, Sanghee Kim, and SaeYoung Lee
    Annals of Surgical Treatment and Research (2014) 86 :136
  • DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients
    António E. Pinto, Teresa Pereira, Márcia Santos, Mariana Branco, Ângelo Dias, Giovani L. Silva, Mónica C. Ferreira, and Saudade André
    Annals of Surgical Oncology (2013) 20 :1530
  • Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: Risk stratification of thyroid follicular cell carcinomas [Review]
    Kennichi Kakudo, Tomoko Wakasa, Yoshio Ohta, Katsunari Yane, Yasuhiro Ito, and Hiroyuki Yamashita
    Endocrine Journal (2015) 62 :1
  • Prognostic value of TMPRSS4 expression in patients with breast cancer
    Bin Liang, Mingzhe Wu, Yuehua Bu, Ainong Zhao, and Fang Xie
    Medical Oncology (2013) 30 :
  • A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer
    Simon A. Fry, John Sinclair, John F. Timms, Anthony J. Leathem, and Miriam V. Dwek
    Cancer Letters (2013) 328 :335